Free public records show Rubicon Research in 15 of the markets we cover. It is not a key player in our research.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
Source: Wikidata, Company record Q7376084. Retrieved 13 Nov 2026.
85 approvals with a product on the US market
Source: Drugs@FDA, Approvals (NDA, ANDA, BLA) held, with a product sold now; newest shown. Retrieved 13 Nov 2026.
4 recalls since 2015 (4 for medicines)
Source: openFDA, FDA enforcement reports (recalls) naming the firm, since 2015. Retrieved 13 Nov 2026.
Markets we cover where free public records show Rubicon Research: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets Rubicon Research is in.
Stories on the topics Rubicon Research works in.
Anaemia affects about half a billion women worldwide, and folic acid before pregnancy prevents serious birth…
Read
Omega-3 supplements are hugely popular. Big trials give mixed answers on whether they protect the heart.
Read
More than 90% of US women and 97% of men do not eat enough fibre. Prebiotics are the fibres that feed helpful…
Read